Post

Feb 17
MRIGlobal Hosts Open House For Paseo’s First Robotics Team

Public event will showcase Paseo/MRIGlobal's 11th FIRST Robotics season.

Kansas City, Mo. – MRIGlobal will host an open house from 3 to 5 p.m. on Monday, February 20, 2017, for the FIRST robotics team from Paseo Academy of Fine and Performing Arts. The event will take place in the MRIGlobal Mag Auditorium, 4920 Cherry St.

This is the eleventh year MRIGlobal has sponsored, mentored, and coached Paseo Academy's FIRST Robotics program.

Monday's event is free and open to the public. Parking is available at the auditorium, which is on the grounds of the MRIGlobal headquarters.

Paseo's robot will compete in the FIRST Regional Robotics Competition March 17-18 at Metropolitan Community College Business and Technology Center, 1775 Universal Avenue, Kansas City, Missouri. The competition is free to attend.

FIRST Robotics was launched by inventor and founder, Dean Kamen.


Feb 14
MRIGlobal Named Kansas City’s Healthiest Employer

MRIGlobal awarded top prize at Feb. 9 event.

Kansas City, Mo. – MRIGlobal was named Healthiest Employer in Kansas City Business Journal's Healthiest Employers competition (100-499 category).

MRIGlobal offers staff on-site wellness coaching, wellness room, nutrition programs, and dozens of programs each year. In 2016, the wellness room was remodeled to include a massage area and the recreation room was added to accommodate playing darts or pingpong.

For decades, MRIGlobal has maintained an on-site gym with an indoor basketball court, an array of fitness equipment, weights, and locker rooms. Outside, there are facilities for sand volleyball and touch football, plus a terraced amphitheater and access to great running/walking trails. During lunch and before and after work, MRIGlobal provides employees and their families with many types of free fitness classes.

This year, 22 companies with local offices made the finalist cut, based on wellness programming and benefits.

Competing employers were split into categories by global workforce size. Healthiest Employers LLC, a data research company, measured those factors. The assessment scored organizations on the wellness program's culture and leadership commitment, foundational components, strategic planning, communication and marketing, programming and interventions, and reporting and analysis.

Feb 06
MRIGlobal Presents “The Role Of Genomics in Emerging Infectious Disease Surveillance” at American Society for Microbiology (ASM) Biothreats Conference

ASM BIOTHREATS: Research, Response, and Policy Conference is Feb. 6-8 in Washington, D.C.

Kansas City, Mo. – MRIGlobal will present an interactive session entitled, "The Role of Genomics in Emerging Infectious Disease Surveillance" at the 2017 ASM Biothreats: Research, Response, and Policy meeting on February 7 in Washington, D.C.

Moderated by MRIGlobal Chief Science Advisor, Chris Detter, Ph.D., the session features experts in One Health Surveillance approaches and practice; science and technology (pathogen genomics and bioinformatics); and regulatory compliance and public health policy implications of pathogen genomics.

MRIGlobal will also showcase technical poster presentations:

  • Ultraportable Technologies for OnSite Arbovirus Surveillance from Mosquitos: Bringing the Lab to the Sample
  • Development and Implementation of Ebola Virus Disease Diagnostics Training in West Africa

The meeting runs from February 6-8 and was formerly known as the ASM Biodefense and Emerging Diseases Research Meeting. The 2017 ASM Biothreats: Research, Response, and Policy meeting is sponsored by the American Society for Microbiology. Held at Marriott Wardman Park, the conference will discuss a wide range of biological threats and emerging infectious diseases to stimulate knowledge-sharing amongst stakeholders in academia, industry and government and help the overlapping communities prepare for, mitigate, and prevent these global threats. The event covers relevant topics in basic and applied research; public health, emergency response and preparedness; and biosecurity, government, and policy responses.
 
About the American Society for Microbiology
The American Society for Microbiology (ASM) is the largest single life science society, composed of over 47,000 scientists and health professionals. ASM's mission is to promote and advance the microbial sciences.

ASM advanced the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of microbial sciences to diverse audiences.


Feb 02
MRIGlobal Among Kansas City’s Healthiest Employers

MRIGlobal is one of seven finalists; first-place winners to be announced Feb. 9.

Kansas City, Mo. – MRIGlobal has been named a finalist in the Kansas City Business Journal's Healthiest Employers awards program. MRIGlobal's Wellness Works offers staff on-site wellness coaching, wellness room, nutrition programs, and dozens of programs each year.


For decades, MRIGlobal has maintained an on-site gym with an indoor basketball court, an array of fitness equipment, weights, and locker rooms. Outside, there are facilities for sand volleyball and touch football, plus a terraced amphitheater and access to great running/walking trails. During lunch and before and after work, MRIGlobal provides staff and their families with many types of free fitness classes.


MRIGlobal is one of seven finalists in the award category for 100-499 employees. The first-place winners in each category of the Healthiest Employer program will be announced at the award breakfast on Thursday, Feb. 9. 


This year, 22 companies with local offices made the cut, based on wellness programming and benefits. Competing employers were split into categories by global workforce size. Healthiest Employers LLC, a data research company, measured those factors. The assessment scored organizations on the wellness program's culture and leadership commitment, foundational components, strategic planning, communication and marketing, programming and interventions, and reporting and analysis.

Feb 01
MRIGlobal Wins $13.7m NIH/NIAID Quality Assessment Contract For Mycobacterium Tuberculosis

MRIGlobal will evaluate technologies and specimen processes to support the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH)


Kansas City, Mo. – MRIGlobal has been awarded a contract (Contract No. HHSN272201700001C) from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to support its Mycobacterium tuberculosis (Mtb) Quality Assessment requirement (known as, “TBQA”).

Under the $13,704,858 (includes the Base Period and all options) contract, MRIGlobal will evaluate Mtb technologies and specimen processes to be used in NIAID-supported clinical investigations and disseminate TBQA technical and scientific data.

Additionally, MRIGlobal will assess the NIAID laboratory network capabilities to accurately and reliably perform study-specific Mtb tests. If any deficiencies are identified, MRIGlobal will advise and train laboratory and clinical site staff.


“We are honored to support NIAID in its research to better understand the development of Tuberculosis drug resistance,” said Roger K. Harris, Ph.D., MRIGlobal Vice President. “The opportunity builds upon our ongoing expertise in global health as it relates to detecting, preventing, and responding to infectious disease and antimicrobial resistance.”   


Tuberculosis (TB) is a contagious and often severe airborne disease caused by infection with Mycobacterium tuberculosis bacteria. TB typically affects the lungs, but it can also affect any other organ of the body, and continues to be one of the major causes of disability and death worldwide.

Nov 08
MRIGlobal’s Design of Next Generation Medevac Biocontainment System Wins R&D Magazine Award as Top 100 Innovation

MRIGlobal's Containerized Bio Containment System (CBCS) wins R&D Magazine's R&D 100 Award


Kansas City, Mo. – MRIGlobal's state-of-the-art, flight-ready Containerized Biocontainment System (CBCS) has been awarded an R&D100 Award for Innovation by R&D Magazine. Each year R&D Magazine presents the awards to 100 of the most technologically significant and innovative technologies introduced to the marketplace over the past year.


Effectively addressing global public health challenges, such as Ebola, requires the commitment of medical professionals. A major recruitment challenge has been limited access to medical evacuation should health workers become ill and need access to medical treatment. To help solve this challenge, a $5 million dollar private-public partnership grant between Paul G. Allen and the State Department was established for the development and manufacture of the CBCS.


MRIGlobal designed the CBCS as a reusable bio-containment and medical treatment unit to operate on government/civilian cargo aircraft. Able to fully contain highly-contagious pathogens, the extremely durable and safe CBCS units allow for the secure transport of healthcare workers abroad. The CBCS can treat four critically ill patients while maintaining biocontainment and safe flight.


"The CBCS was designed to save lives," said Dean Gray, Ph.D., Director of Special Programs, MRIGlobal. "There's nothing like this in the world right now and it was developed in response to an urgent need. With CBCS, the world is ready for the next big event."


See the video here: https://youtu.be/RI7WcxRSWhA


Winners were presented with their honors at the 54th Annual R&D Awards dinner on November 3.

Nov 03
MRIGlobal’s Design of Next Generation Medevac Biocontainment System Named Finalist In Innovation Awards

MRIGlobal’s Containerized Bio Containment System, designed and fabricated in just 191 days, is a finalist in R&D Magazine’s R&D 100 Awards

Kansas City, Mo. – MRIGlobal’s state-of-the-art, flight-ready Containerized Biocontainment System (CBCS) has been named a finalist by R&D Magazine for the coveted 2016 R&D 100 Awards.

Effectively addressing global public health challenges, such as Ebola, requires the commitment of medical professionals. A major recruitment challenge has been limited access to medical evacuation should health workers become ill and need access to medical treatment. To help solve this challenge, a $5 million dollar private-public partnership grant between Paul G. Allen and the State Department was established for the development and manufacture of the CBCS.

Designed by MRIGlobal, the CBCS is a reusable bio-containment and medical treatment unit, designed to be operated on government/civilian cargo aircraft. The CBCS are designed to fully contain highly-contagious pathogens. The units are extremely durable and safe, which will allow for the secure transport of healthcare workers abroad. The CBCS can treat four critically ill patients while maintaining biocontainment and safe flight.

“The CBCS was designed to save lives,” said Dean Gray, Ph.D., Director of Special Programs, MRIGlobal. “There’s nothing like this in the world right now and it was developed in response to an urgent need.”

See the video here: https://youtu.be/RI7WcxRSWhA

Considered to be the Oscars of Innovation, each year R&D Magazine presents the awards to 100 of the most innovative technologies and services of the past year. Winners will be presented with their honors at the annual awards dinner on November 3.

Oct 17
MRIGlobal, in Partnership with Thermo Fisher Scientific and ASU, to Lead Testing of Diagnostic Medical Countermeasures Program for U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness Response (ASPR)

ASPR's Biomedical Advanced Research and Development Authority (BARDA) will provide up to $100M over 10 years to the MRIGlobal Team to conduct advanced development for a qPCR-based quantitative biodosimetry assay (ARad Biodosimetry Test) and validation testing in support of a 510(k) submission to the FDA.

Kansas City, Mo. – MRIGlobal, with key partners Thermo Fisher Scientific and Arizona State University (ASU), will lead a molecular biodosimetry development program for the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness Response within the U.S. Department of Health and Human Services. The contract, worth more than $21.3 million over the first four years and three months, could be extended for up to $100 million over 10 years.

The ARad Biodosimetry Test is a diagnostic test designed to determine absorbed doses of ionizing radiation and inform the use of medical countermeasures to administer medical care following a radiation or nuclear incident. The ARad Biodosimetry Test was developed by researchers at ASU's Biodesign Institute and Thermo Fisher Scientific and is designed to be run in a clinical health care laboratory that produces a quantitative estimate of the actual absorbed dose a person received.

MRIGlobal, with partners Thermo Fisher Scientific and ASU, will clinically test and validate the ARad Biodosimetry Test for FDA clearance. The FDA-cleared test will be manufactured by Thermo Fisher Scientific and stockpiled for available testing.

Using the ARad Biodosimetry Test, blood samples will be analyzed for up to seven days post exposure to measure how genes respond to different amounts of radiation, and the test is expected to generate results in approximately eight hours. This test provides rapid response capabilities and high throughput sample analysis with the potential to process 400,000 or more tests a week.

"This work is critical to saving lives in the event of a nuclear or radiological emergency," said Thomas M. Sack, Ph.D., President and Chief Executive Officer, MRIGlobal, "Current tests only detect radiation on the skin, but there are no biodosimetry tests approved to measure the amount of radiation absorbed into the body."

"This technology contributes a critical capability to the nation's preparedness for a major radiation-related emergency," said Joshua LaBaer, M.D., Ph.D., Interim Executive Director of ASU's Biodesign Institute and Director of the Biodesign Virginia G. Piper Center for Personalized Diagnostics. "Rapid and precise tracking of gene expression resulting from radiation exposure will allow clinicians to fast-track patients based on absorbed radiation dose, ensuring the best medical outcomes in the event of a catastrophic incident."

Aug 29
MRIGlobal Furthers Study of Zika Virus Infection Resulting in Microcephaly Using 2016 Patton Trust Research Development Grant

$50K Grant was awarded by The Kansas City Area Life Sciences Institute

Kansas City, Mo. – MRIGlobal will further study Zika virus infection resulting in microcephaly. The study will be funded by a newly awarded research development grant from the Paul Patton Trust, Ted C. McCarter, William Evans Jr., Bank of America N.A.

The $50,000 grant was awarded by The Kansas City Area Life Sciences Institute to support research focused on genetic diseases affecting children.

Zika Virus Infection Resulting In Microcephaly

MRIGlobal will collaborate with the University of Missouri to develop unique animal models to investigate Zika virus infection. The mosquito-borne virus can be passed from mother to fetus via an unknown mechanism, resulting in reduced head circumference due to incomplete brain development called microcephaly. Individuals with this condition have many disabilities. Although there are no treatments for the physical abnormalities associated with this condition, therapies can control seizures, hyperactivity, and other symptoms.

"Zika virus is not well researched and is now known to cause serious birth defects. There is a desperate need to understand how the virus spreads through mosquitos and from mother to baby," says Carl Gelhaus, Ph.D., Principal Scientist at MRIGlobal. "Our research through animal models will examine how Zika virus spreads to provide tools to the research community and better understand how Zika virus causes microcephaly in a developing fetus. Our hope is that we will identify drug and vaccine targets that can be further developed to stop the devastating effects of Zika virus infection."  

"These grants fund research focused on genetic diseases that primarily affect children and may lead to life-changing discoveries and treatments," said Dr. Wayne Carter, KCALSI's president and chief executive officer.  "We value our relationship with the Paul Patton Trust, Ted C. McCarter, William Evans Jr., and Bank of America Trustees, the corporate co-trustee, for funding these research grants.  Historically for every dollar invested in these grants, over $8.50 has been returned to the community and researchers in future grant dollars because these grants allow the recipients to successfully compete for much larger, federally funded grants that can provide hundreds of thousands of dollars for follow-on research." KCALSI has managed the scientific review of the Patton Trust grant proposals since 2007, identifying research programs with the greatest scientific relevance and potential impact.

About MRIGlobal

MRIGlobal, an independent research and development organization, delivers solutions in global health, national security and defense, and energy and the environment. The organization performs scientific research, advanced engineering, and program integration and management for clients in industry, government, and academia. Established in 1944 as Midwest Research Institute, MRIGlobal is based in Kansas City, Mo., and operates in nine states and Washington, D.C. MRIGlobal employs more than 500 and manages 2,600-plus workers through management and operations programs with various clients.

For more information, visit www.mriglobal.org.

About Kansas City Area Life Sciences Institute (KCALSI)

Through its Research Development Grants program, KCALSI manages a variety of individual grants for area corporations and trusts, helping them identify proposals with the best scientific, medical and technical merit. Research grants are awarded to generate initial results and stimulate the submission of major multidisciplinary research proposals to government or private agencies. KCALSI's Research Development Grants program includes proposal review, evaluation by subject matter experts, written reviews for all applicants, and post-award management. For more information, visit www.kclifesciences.org.

Aug 26
MRIGlobal Adds New Trustees

Steve Edwards, Chairman and Chief Executive Officer, Black & Veatch

Jewel D. Scott, Executive Director, Civic Council of Greater Kansas City

Maurice Watson, Chairman, Husch Blackwell

Three add key expertise in engineering, business, government, law

edwards.pngscott.pngwatson.jpg 

Kansas City, Mo. – MRIGlobal announced that its Board of Directors has elected three new members to the MRIGlobal Board of Trustees.

MRIGlobal's Board of Directors govern and direct the leadership of the organization while the 124 members of the Board of Trustees serve in an advisory capacity to the Board of Directors.

The three newly appointed trustees are:

  • Steve Edwards, Chairman and Chief Executive Officer, Black & Veatch
  • Jewel D. Scott, Executive Director, Civic Council of Greater Kansas City
  • Maurice Watson, Chairman, Husch Blackwell

"Our trustees serve as MRIGlobal's ambassadors to the community to advocate our efforts in making the world safer, healthier, and more sustainable," said Tom Bowser, MRIGlobal Chairman of the Board of Directors. "We proudly welcome Steve Edwards, Jewell Scott, and Maurice Watson to our prestigious Board of Trustees."  

Bowser became a member of the MRIGlobal Board of Trustees in 2008 and was named Chairman of the Board of Directors in 2014.

"The role of our Trustees cannot be understated," Thomas M. Sack, Ph.D., President and Chief Executive Officer, MRIGlobal. "We are grateful that Steve, Jewell, and Maurice bring their time, expertise, and broad reach to help promote MRIGlobal's mission." 

Steve Edwards is Chairman and Chief Executive Officer of Black & Veatch. He is responsible for the company's engineering, consulting, construction and related infrastructure businesses in the power, oil and gas, water, telecommunications, and security markets worldwide. With revenues of $3 billion, Black &Veatch is ranked in the Top 150 of Forbes list of Largest Private Companies and is the 12th largest employee-owned corporation in the United States, according to the National Center for Employee Ownership.

Jewel D. Scott became Executive Director of the Civic Council of Greater Kansas City in 1994, having served as Director of Research and Planning. Before joining the Civic Council's staff, she was a city manager and had previous experience as a member of the City Manager's staff in Kansas City, Missouri and as a journalist. Ms. Scott serves on the Missouri Biotechnology Association's Executive Committee and was a founding board member of the Kansas City Area Life Sciences Institute.

As Chairman of Husch Blackwell, Maurice Watson is responsible for developing and communicating the firm's strategic direction and ensuring that its policies and culture align with this direction. He is a member of the firm's healthcare, life sciences, and education industry team. His law practice focuses on representation of educational institutions, colleges and universities, and regional and national education associations.

1 - 10Next